About this trial
ASD is a very complex and lifelong disorder. Patients' functioning is influenced by multiple factors, including treatments, inclusion and life contexts. Nonetheless, outcome measures are still point-specific and highly fragmented, rarely considering global or multidimensional functioning, development or long-term modifications, especially in the real world. The present study considers ongoing real-life treatments in three different NHS settings, in line with the Italian Guidelines. Two age classes will be considered, 0-5 and 6-11, adding new outcome tools pre-post intervention to those already used, to evaluate quality of life, global functioning, multidimensional needs and strengths and shared decision making. Correlations between the different outcome tools will be explored, and possible clusters will be investigated. Acceptability of the outcome tools for the operators, patients and families, as well as usefulness and sustainability in daily practice, will also be evaluated.
Eligibility criteria
Qualifiers
ASD diagnosis according to the criteria shared by the regional NFA network
Age under 12
Consent from the person holding parental responsibility for health choices
Disqualifiers
Subjects aged 12 years or older at the time of enrollment
No consent from the person holding parental responsibility for health choices
Trial design
Treatments tested in this trial
- DD-CGAS (Wagner et al. 2007)
- Pediatric Quality of Life Inventory (PedsQL).
- Child and Adolescent Needs and Strengths (CANS) (Lyons 2022)
Treatment groups
Sponsors and collaborators
Antonella Costantino
Lead sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Sponsor institution
IRCCS Eugenio Medea
Collaborator
Azienda Socio Sanitaria Territoriale della Valle Olona
Collaborator